MedImmune President Peter Greenleaf to Discuss State of the Life Sciences Industry at Tech Council of Maryland's MdBio Leadership Series Breakfast

Published: Aug 31, 2012

ROCKVILLE, MD--(Marketwire - August 30, 2012) -

Highlighted Links

Tech Council of Maryland

MedImmune

WHO:
The Tech Council of Maryland (TCM)

WHAT:
MdBio Leadership Series with Peter Greenleaf, President of MedImmune

WHERE:
Bethesda North Marriott Hotel & Conference Center
5701 Marinelli Road
Bethesda, MD 20852

WHEN:
Thursday, September 6, 2012
8 a.m. to 10 a.m.

WHY:
The biopharmaceutical industry has experienced major changes in the past few years with more changes expected to come. Greenleaf will provide his perspectives on the state of the global biotech industry and critical business, regulatory, and government issues that are impacting the industry.

As Chairman of the Maryland Venture Fund Authority, Greenleaf also will discuss recent developments within the Maryland life sciences industry, including an update on the InvestMaryland venture capital initiative. In addition, he will discuss opportunities for life sciences companies in Maryland to showcase themselves on the global stage.

ATTEND:
To register or for more information, please visit the Tech Council of Maryland's website.

ABOUT THE TECH COUNCIL OF MARYLAND, INC.
The Tech Council of Maryland (TCM) is the largest technology trade group serving the advanced technology and biotechnology communities of Maryland. TCM's mission is to advocate for the interests of the technology community, further the role of technology in the Maryland economy, and nurture an environment where technology companies can collaborate, grow and succeed. For more information, visit www.techcouncilmd.com.